HSIL lesion of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_HSIL

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

198506

diagram downward connector

Check conditions None

198506

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D06, D07.1&, D07.2&, N87.1, N87.2, N89.1, N89.2, N90.1, N90.2
Hospital discharge: ICD-9 6221B|6221C|2331A|2333A|6230B|6230C|2333B
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D06, D07.1&, D07.2&, N87.1, N87.2, N89.1, N89.2, N90.1, N90.2
Cause of death: ICD-9 6221B|6221C|2331A|2333A|6230B|6230C|2333B
Cause of death: ICD-8 $!$

5427

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

5427

diagram downward connector

Check minimum number of events None

5427

diagram downward connector

Include endpoints None

5427

diagram downward connector
N14_FEMALE_GENITAL_HSIL

Extra metadata

First used in FinnGen datafreeze DF7

Similar endpoints

List of similar endpoints to HSIL lesion of the cervix uteri, vagina or vulva based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 5427 5427 -
Unadjusted prevalence (%) 1.53 2.74 -
Mean age at first event (years) 38.42 38.42 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 0.98 [0.40, 2.37] 9.6e-1 110
15 years 0.01 0.78 [0.36, 1.70] 5.3e-1 46
5 years 0.00 1.86 [0.92, 3.76] 8.4e-2 26
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: N14_FEMALE_GENITAL_HSIL – HSIL lesion of the cervix uteri, vagina or vulva
GWS hits: 2

Survival analyses between endpoints

Plot

before HSIL lesion of the cervix uteri, vagina or vulva
after HSIL lesion of the cervix uteri, vagina or vulva

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after HSIL lesion of the cervix uteri, vagina or vulva